Hydroxycobalamin and Rural Emergency Medical Services Cyanide Exposure Patients: A Cost Analysis

Sponsor
MaineHealth (Other)
Overall Status
Withdrawn
CT.gov ID
NCT01656616
Collaborator
(none)
0
1

Study Details

Study Description

Brief Summary

The costs to a rural emergency medical services (EMS) system of a change from a traditional cyanide antidote kit to a kit containing hydroxocobalamin alone are currently unknown. The purpose of this study is to use current EMS data to calculate the costs to a rural EMS system associated with the adoption of a hydroxocobalamin protocol for the treatment of suspected cyanide exposure.

Condition or Disease Intervention/Treatment Phase
  • Drug: Cyanide antidote administration

Study Design

Study Type:
Observational
Actual Enrollment :
0 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Hydroxycobalamin and Rural Emergency Medical Services Cyanide Exposure Patients: A Cost Analysis
Actual Study Start Date :
Aug 1, 2012
Actual Primary Completion Date :
Aug 1, 2012
Actual Study Completion Date :
Aug 1, 2012

Arms and Interventions

Arm Intervention/Treatment
EMS cyanide exposure patients

Drug: Cyanide antidote administration

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Included in Maine EMS database

    • House Fire Victim

    • Poisoning

    Exclusion Criteria:
    • No potential cyanide exposure

    • Incomplete data available

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Maine Medical Center Department of Emergency Medicine Portland Maine United States 04102

    Sponsors and Collaborators

    • MaineHealth

    Investigators

    • Study Director: Tania D Strout, PhD, RN, MS, MaineHealth

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Katrina G. Ferguson, Director of Research, Department of Emergency Medicine, MaineHealth
    ClinicalTrials.gov Identifier:
    NCT01656616
    Other Study ID Numbers:
    • IRB 4053X
    First Posted:
    Aug 3, 2012
    Last Update Posted:
    May 18, 2017
    Last Verified:
    May 1, 2017
    Keywords provided by Katrina G. Ferguson, Director of Research, Department of Emergency Medicine, MaineHealth
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 18, 2017